Anti-CD38 Nanoantibody (JK36) Allows Detection of Minimal Residual Disease in Multiple Myeloma Patients Treated with Daratumumab

被引：0
|
作者：
Souto, Elizabeth Xisto [1 ]
Bento, Laiz Cameirao [1 ]
Sousa, Flavia Arandas [1 ]
Passaro, Marilia Sandoval [1 ]
Vaz, Andressa Da Costa [1 ]
Schimidell, Daniela [1 ]
Bueno, Barbara Faziali [1 ]
Myiamoto, Priscila Carmona [1 ]
Nogueira, Bruna Garcia [1 ]
Guerra, Joao Carlos [2 ]
Villarinho, Andrea Rocco
Bacal, Nydia [1 ]
机构：
[1] Albert Einstein Hosp, Lab Flow Cytometry, Sao Paulo, Brazil
[2] Albert Einstein Hosp, Lab, Sao Paulo, Brazil
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182757
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] ANTI-CD38 NANOBODY JK36 ALLOWS RELIABLE MINIMAL RESIDUAL DISEASE (MRD) DETECTION IN DARATUMUMAB TREATED MULTIPLE MYELOMA (MM) PATIENTS
    Meseguer, Elena
    Marco, Josefa
    Garcia, Ana
    Ribas, Paz
    Jose Fernandez, Maria
    Lopez, Amparo
    Roseta, So A.
    Frances, Eva
    Cortes, Omara
    Ivars, David
    Gomez, Elena
    Donato, Eva
    Fernandez, Miguel
    Panero, Miriam
    Jose Cejalvo, Maria
    Jose Sayas, Maria
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 118 - 119
  • [2] Anti-CD38 VHH antibody JK36 reliably detects CD38 in daratumumab treated multiple myeloma patients with high relevance for MRD diagnostics
    Ecker, V
    Mueller, M. L.
    Haferlach, C.
    Haferlach, T.
    Kern, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 232 - 233
  • [3] Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies
    Caroni, Federico
    Sammartano, Vincenzo
    Pacelli, Paola
    Sicuranza, Anna
    Malchiodi, Margherita
    Dragomir, Andreea
    Ciofini, Sara
    Raspadori, Donatella
    Bocchia, Monica
    Gozzetti, Alessandro
    PHARMACEUTICALS, 2025, 18 (02)
  • [4] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
    Saltarella, Ilaria
    Desantis, Vanessa
    Melaccio, Assunta
    Solimando, Antonio Giovanni
    Lamanuzzi, Aurelia
    Ria, Roberto
    Storlazzi, Clelia Tiziana
    Mariggio, Maria Addolorata
    Vacca, Angelo
    Frassanito, Maria Antonia
    CELLS, 2020, 9 (01)
  • [5] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
    Richardson, P.
    Lokhorst, H.
    Palumbo, A.
    Nahi, H.
    Laubach, J.
    Gimsing, P.
    Lisby, S.
    Cakana, A.
    Brun, N. Constantin
    Plesner, T.
    DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
  • [6] Serological Investigation in a Multiple Myeloma Patient receiving Daratumumab (Anti-CD38)
    Oldfield, L.
    Ison, T.
    Lau, W.
    TRANSFUSION, 2016, 56 : 135A - 136A
  • [7] Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab
    Thirkettle, Sally
    Russell, Joanne
    Wilson, Sarah
    Ganijee, Tasneem
    Kulkarni, Samar
    Cavet, Jim
    Monaghan, Phillip J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2020, 57 (02) : 178 - 181
  • [8] Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti-CD38 Monoclonal Antibodies: A Systematic Review
    Tan, Chia Jie
    Kacerek, Dylan
    Kampirapawong, Nattawara
    Godara, Amandeep
    Chaiyakunapruk, Nathorn
    CANCER MEDICINE, 2025, 14 (05):
  • [9] Case report: serological testing interference of daratumumab (anti-CD38) therapy in multiple myeloma
    Rabut, Elodie
    Castro-Fernandez, Annabelle
    Le Gall, Virginie
    Meknache, Nihad
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (03) : 351 - 355
  • [10] Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma
    Tan, Carlyn Rose Co
    Rueda, Colin
    Shekarkhand, Tala
    Derkach, Andriy
    Korde, Neha
    Maclachlan, Kylee
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi A.
    Rajeeve, Sridevi
    Lahoud, Oscar Boutros
    Shah, Gunjan L.
    Scordo, Michael
    Chung, David J.
    Landau, Heather Jolie
    Giralt, Sergio
    Usmani, Saad Zafar
    Lesokhin, Alexander M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345